Coloplast Gross Profit vs. Revenue
| COLO-B Stock | DKK 894.20 3.60 0.40% |
For Coloplast profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Coloplast to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Coloplast AS utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Coloplast's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Coloplast AS over time as well as its relative position and ranking within its peers.
Coloplast |
Coloplast AS Revenue vs. Gross Profit Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Coloplast's current stock value. Our valuation model uses many indicators to compare Coloplast value to that of its competitors to determine the firm's financial worth. Coloplast AS is number one stock in gross profit category among its peers. It also is the top company in revenue category among its peers totaling about 1.45 of Revenue per Gross Profit. Comparative valuation analysis is a catch-all model that can be used if you cannot value Coloplast by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Coloplast's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Coloplast Revenue vs. Gross Profit
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Coloplast |
| = | 15.53 B |
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Coloplast |
| = | 22.58 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Coloplast Revenue vs Competition
Coloplast AS is the top company in revenue category among its peers. Market size based on revenue of Medical Instruments & Supplies industry is currently estimated at about 289.02 Billion. Coloplast holds roughly 22.58 Billion in revenue claiming about 8% of all equities under Medical Instruments & Supplies industry.
Coloplast Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Coloplast, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Coloplast will eventually generate negative long term returns. The profitability progress is the general direction of Coloplast's change in net profit over the period of time. It can combine multiple indicators of Coloplast, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Coloplast AS develops and markets intimate healthcare products and services worldwide. Coloplast AS was founded in 1954 and is headquartered in Humlebk, Denmark. Coloplast operates under Healthcare Products classification in Denmark and is traded on Copenhagen Stock Exchange. It employs 12000 people.
Coloplast Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Coloplast. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Coloplast position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Coloplast's important profitability drivers and their relationship over time.
Use Coloplast in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Coloplast position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coloplast will appreciate offsetting losses from the drop in the long position's value.Coloplast Pair Trading
Coloplast AS Pair Trading Analysis
The ability to find closely correlated positions to Coloplast could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Coloplast when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Coloplast - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Coloplast AS to buy it.
The correlation of Coloplast is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Coloplast moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Coloplast AS moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Coloplast can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Coloplast position
In addition to having Coloplast in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Aggressive Defence Thematic Idea Now
Aggressive Defence
Macroaxis small cap, aggressive-outlook picks designed for investors that are willing to accept higher levels of risk to hedge exposure to above-average market volatility. The Aggressive Defence theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aggressive Defence Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Coloplast Stock
To fully project Coloplast's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Coloplast AS at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Coloplast's income statement, its balance sheet, and the statement of cash flows.